DNA tests grow more vital in hereditary breast cancer treatments. They also raise unanswerable questions.
By Sarah Elizabeth Richards,
Washington Post
| 03. 15. 2020
When Lisa DeAngelico found out she had Stage 4 breast cancer two years ago at age 47, she says one of the hardest parts about her diagnosis was telling her mother. That’s because her mother had already lost her sister and niece to the disease. They had hoped DeAngelico would be spared from the family curse.
So when DeAngelico’s doctor asked her whether she wanted to undergo DNA testing to better understand her family genetics, she agreed to offer a blood sample and meet with a genetic counselor.
“I hoped that if it did tell me I had a gene, I could tell others in my family that they should get tested early,” says DeAngelico, a hospital administrative coordinator in East Boston.
Surgeons say all breast cancer patients should be offered genetic testing
Yet the results revealed more than a family connection. When her doctor learned that DeAngelico had a mutation in the BRCA2 gene, he explained she also had a risk of ovarian cancer and advised her to have her ovaries and fallopian tubes removed to prevent the cancer...
Related Articles
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Katherine Drabiak, Journal of Medical Ethics Forum | 08.07.2025
Adapted from Mitochondrial DNA at
National Human Genome Research Institute
Recently, media outlets around the world have been reporting on children born from pronuclear genome transfer (sometimes called “3-parent IVF,” “mitochondrial donation” or “mitochondrial replacement therapy”) at Newcastle Fertility Center...
By Nicky Hudson, The Conversation | 08.12.2025
